-
Cost-Effectiveness of First-Line Atezolizumab versus Chemotherapy in Non-Small-Cell Lung Cancer Patients Ineligible for Platinum-Containing Regimens
11 Apr 2024 16:52 GMT
… for non-small-cell lung cancer (NSCLC) patients ineligible … 7,8 of all lung cancers cases, with nearly … -cell lung cancer: a cost-effectiveness analysis. Translational Lung Cancer Res. … docetaxel in patients with previously treated non-small-cell lung cancer …
-
Effectiveness and Safety of Anlotinib Combined with PD-1 Blockades in Patients with Previously Immunotherapy Treated Advanced Non-Small Cell Lung Cancer: A Retrospective Exploratory Study
25 Mar 2024 10:25 GMT
… non-small-cell lung cancer. Clin Lung Cancer. 2021;22(1 … versus docetaxel in previously treated non-small-cell lung cancer. J … non-small-cell lung cancer patients. Clin Lung Cancer. 2020;21( … non-small cell lung cancer (NSCLC). Transl Lung Cancer Res. 2015; …
-
Two Datopotamab Deruxtecan Applications Validated in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer or HR Positive, HER2 Negative Breast Cancer
04 Mar 2024 10:29 GMT
… nonsquamous non-small cell lung cancer (NSCLC) who require … of datopotamab deruxtecan versus docetaxel in patients with locally … -Small Cell Lung Cancer
Nearly 500,000 lung cancer cases were …
References:
1 Cancer.net. Lung Cancer – Non-Small Cell: Statistics …
-
Two datopotamab deruxtecan applications validated in the EU for patients with advanced nonsquamous non-small cell lung cancer or HR-positive, HER2-negative breast cancer
04 Mar 2024 08:08 GMT
… nonsquamous non-small cell lung cancer (NSCLC) who require … for datopotamab deruxtecan in lung cancer and breast cancer are … non-small cell lung cancer
Nearly 500,000 lung cancer cases were … of datopotamab deruxtecan versus docetaxel in patients with locally …
-
Docetaxel Market is Booming Worldwide | Beijing Union Pharmaceutical, Phyton, Actavis
25 Mar 2024 15:29 GMT
… is the Docetaxel Market?
The Docetaxel Market refers … and, region.
Global Docetaxel Market Breakdown by Type … cancer, Non-small cell lung cancer, Gastric cancer) by …
• Docetaxel Market Outlook (2024-2030)
• Docetaxel Market Trends
• Docetaxel Market …
-
BeiGene Receives Positive CHMP Opinion for Tislelizumab as Treatment for Non-Small Cell Lung Cancer
26 Feb 2024 10:26 GMT
… for non-small cell lung cancer (NSCLC) across three indications … trial with tislelizumab versus docetaxel that enrolled 805 patients … and dyspnea.
About NSCLC
Lung cancer is the second most … lung cancers.2 In 2020, the number of new cases of lung cancer …
-
Dato-DXd to Be Reviewed by FDA for Metastatic Lung Cancer Treatment
22 Feb 2024 00:18 GMT
… nonsquamous non-small cell lung cancer (NSCLC) that received … nonsquamous non-small cell lung cancer an effective and tolerable … disease worsens) compared to docetaxel, which is the current … nonsquamous non-small cell lung cancer after disease progression on …
-
AstraZeneca-Daiichi Sankyo application for Datopotamab deruxtecan accepted in US for patients with previously treated advanced nonsquamous non-small cell lung cancer
19 Feb 2024 15:52 GMT
… -free survival (PFS) compared to docetaxel, the current standard of care … numerically favoured datopotamab deruxtecan over docetaxel in the overall population; however … advanced nonsquamous non-small cell lung cancer an effective and tolerable alternative …
-
Daiichi Sankyo and AstraZeneca’s lung cancer antibody set for FDA review
19 Feb 2024 15:28 GMT
… year for AstraZeneca in lung cancer treatments. Following another … in many types of lung cancers.
The drug has … with collaboration from AstraZeneca. Lung cancer patients treated with Dato … taking the chemotherapy drug docetaxel, the current standard of …
-
Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer
19 Feb 2024 12:19 GMT
… -small cell lung cancer
Nearly 250,000 lung cancer cases were … improvements for people with lung cancer, including and beyond treatment … . Docetaxel in the Treatment of Non-small Cell Lung Cancer (NSCLC … TROP2 in non‐small lung cancers and its correlation with …